CVRx vs Lensar
CVRX and LNSR side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVRX and LNSR compare
Lensar is the larger company, worth 3.7 times as much as CVRx ($60.3M against $16.3M).
CVRx grew revenue faster over the last twelve months (12.0% versus 3.3% for Lensar).
Lensar keeps more of each dollar of sales as profit, with a net margin of 57.6% compared with −84.9% at CVRx.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVRX | LNSR |
|---|---|---|
| Size and price | ||
| Market cap | $16.3M | $60.3M |
| Share price | $0.611 | $4.91 |
| Change, 1 year | −93.4% | −51.4% |
| Change, 5 years | −95.3% | −30.0% |
| Beta (5Y) | −0.96 | 1.61 |
| Employees | 223 | 150 |
| StockData Score | ||
| Total score | 8 | 8 |
| Valuation score | 3 (better) | 2 |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 2 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× (better) | 1.0× |
| P/B | 0.8× (better) | 4.0× |
| FCF yield | −252% | – |
| Fair value | $7.11 | $6.31 |
| Margin of safety | 91.4% (better) | 22.2% |
| Growth | ||
| Revenue growth (TTM) | 12.0% (better) | 3.3% |
| Revenue growth, 5Y average | 56.4% (better) | 17.2% |
| Profitability | ||
| Gross margin | 86.9% (better) | 48.3% |
| Operating margin | −79.5% | −13.5% (better) |
| Net margin | −84.9% | 57.6% (better) |
| FCF margin | −67.1% | – |
| Return on equity | −133% | – |
| Return on invested capital | −293% | – |
| Financial health | ||
| Debt / equity | 2.94 | 0.25 (better) |
| Interest coverage | −8.1× | – |
| Current ratio | 8.04 (better) | 2.39 |
| Altman Z-score | −9.29 | −0.93 (better) |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Buyback yield | −2.9% | – |
| Shareholder yield | −2.9% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 57.4% | 36.0% |
| Held by insiders | 49.9% | – |
| Insider net buying, 12 months | $247K | – |
| Short interest, % of float | 13.6% | – |
Go deeper
- CVRX stock overview
- CVRX income statement
- CVRX valuation and score
- LNSR stock overview
- LNSR income statement
- LNSR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.